Learn more

ZENTARIS AG

Overview
  • Total Patents
    274
About

ZENTARIS AG has a total of 274 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, Australia and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are JIANGSU SIMCERE PHARMACEUTICAL R & D CO LTD, BIOMEASURE INC and ABBVIE INC.

Patent filings per year

Chart showing ZENTARIS AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Nickel Bernd 52
#2 Kutscher Bernhard 49
#3 Emig Peter 44
#4 Engel Juergen 43
#5 Guenther Eckhard 43
#6 Beckers Thomas 38
#7 Reissmann Thomas 32
#8 Bauer Horst 29
#9 Damm Michael 24
#10 Schmidt Juergen 22

Latest patents

Publication Filing date Title
CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
DE10232525A1 New diazaheterocyclylcarbonyl-anthracene derivatives, useful as tubulin polymerization inhibitors for treating benign or malignant tumors
DE10203195A1 Use of alkylphosphocholines in the preventive treatment of protozoal diseases
DE10157628A1 Solution for injection of an LHRH antagonist
DE10143079A1 Cyclic indole and heteroindole derivatives, their production and use as medicines
DE10137174A1 Method of modifying T-cell populations, e.g. for treatment of HIV infection or cancer, comprises administrating luteinizing hormone releasing hormone antagonist at controlled dose insufficient to cause chemical castration
UA73356C2 Compounds elevating growth hormone secretion
DE10122523A1 New 1,3-dihydroxybenzo-fused decalactone compounds, are cellular kinase inhibitors and hormone receptor inhibitors, useful as e.g. antitumor, anti-infective, antifungal and antiprotozoal drugs
IL151647D0 Novel lhrh-antagonists, production and use thereof as medicament
US2001008885A1 Methods of treating protozoal diseases
TW200800298A Compressed microparticles for dry injection
CO5160256A1 SALTS OF PHARMACEUTICALLY ACTIVE PEPTIDES FOR SUSTAINED RELEASE AND PRODUCTION PROCESS
AU5709299A Novel synthetic reaction and targeted cytotoxic anthracycline analogs obtained thereby
AU6212198A Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis